Abstract: Human amnion cells in primary culture respond to glucocorticoids in a characteristic fashion by the increased expression of the inducible prostaglandin endoperoxide H synthase isoenzyme, PGHS-2. Since PGHS-2 induction by agonists generally involves tyrosine kinases, we examined the possibility that the glucocorticoid stimulation of PGHS-2 in the amnion cells is tyrosine kinase dependent. PGHS-2 expression was stimulated in confluent, serum-starved amnion cells with dexamethasone, and the effect of the tyrosine kinase inhibitors herbimycin A and tyrphostins AG126, AG1288, and A1 on enzyme activity induction was determined. All four inhibitors blocked the increase of PGHS activity in a concentration-dependent manner with IC 50 values of 0.077 ± 0.05, 15.38 ± 5.14, 20.91 ± 3.1, and 29.77 ± 8.21 µM, respectively (mean ± SE, n = 4). Dexamethasone increased (approximately twofold) the tyrosine phosphorylation of 120-, 110-, and 77-kDa proteins in cell extracts, and herbimycin A selectively blocked the phosphorylation of the 110-kDa phosphoprotein. The stimulation of the steady-state level of PGHS-2 mRNA by dexamethasone was also inhibited by herbimycin A. These results suggest that glucocorticoids induce PGHS-2 expression in amnion cells with the involvement of tyrosine kinase(s). The role of tyrosine kinase dependent mechanisms in the control of amnion cell responsiveness to corticosteroids remains to be established.
Introduction
Glucocorticoids stimulate the expression of prostaglandin endoperoxide H synthase 2 (PGHS-2) in primary cultures of human amnion cells . This response is characteristic of amnion cells, since glucocorticoid treatment inhibits PGHS-2 expression in numerous other cell types in vitro and in vivo (Goppelt-Stuebe 1995) . The induction of PGHS-2 is isoenzyme selective, because the level of PGHS-1 mRNA remained undetectable following dexamethasone treatment. Furthermore, PGHS-2 mRNA abundance was increased independently of protein synthesis and was blocked by glucocorticoid antagonist, indicating a primary type of response with the involvement of the glucocorticoid receptor. Dexamethasone did not influence the stability of PGHS-2 mRNA, which suggested that the steroid promoted the synthesis of the messenger RNA.
PGHS-2 expression increases in the amnion membrane with labor . This contributes to the increase of intrauterine prostaglandin production associated with parturition. Therefore, the tissue-specific enhancement of the PGHS-2 level in the human amnion is a potentially important step in the process leading to labor onset and birth. The way glucocorticoid hormones are involved in this regulation is unclear, although cortisol levels rise in the amniotic fluid at late gestation and cortisol induces PGHS-2 expression in cultured amnion cells, as outlined above. Moreover, the central role of fetal cortisol in the initiation of parturition is well established in other species such as the sheep (Challis and Hooper 1989) .
Tyrosine kinases were implicated in the regulation of PGHS-2 expression in a variety of cells. Tyrosine kinase inhibitors were reported to block PGHS-2 expression induced by endotoxin, inflammatory cytokines, gonadotropins, growth factors, phorbol ester, and okadaic acid (for review see Zakar et al. 1998) . Furthermore, the phosphotyrosine phosphatase inhibitor vanadate was shown to promote PGHS-2 expression (Hirai et al. 1997 ). The pervasive involvement of tyrosine kinase dependent mechanisms in the control of PGHS-2 expression suggested the possibility that the induction of the enzyme by glucocorticoids in the amnion cells may also require the activity of tyrosine kinase(s). In the present investigation, we tested this possibility by examining the influence of various tyrosine kinase inhibitors on the stimulation of PGHS-2 activity and mRNA levels by dexamethasone in primary amnion cell cultures. The results provided evidence supporting an essential role of tyrosine kinase activity in the glucocorticoid-elicited rise of PGHS-2 expression.
Materials and methods

Cell culture
Amnion cells were isolated by enzymatic dispersion from reflected amnion membranes obtained after spontaneous term delivery, as described previously . The use of the tissues was approved by the appropriate institutional ethics review board. Primary cell cultures were maintained in a 1:1 mixture of Dulbecco's modified Eagle medium (DMEM) and Ham's F12 nutrient mixture containing 10 mM Hepes (DMEM-F12) and supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS), 5 ng·mL -1 epidermal growth factor, and 1 µM cortisol. Confluence was reached in 6-8 days, then DMEM-F12 with 1% FBS was added to the cultures for 2 days to achieve quiescence. Cells used for mRNA and tyrosine phosphorylated protein analysis were grown in T75 flasks, while cells used for PGHS activity determinations were cultured in 24-well cluster plates.
Experimental treatments
Stock solutions of herbimycin A and tyrphostins AG126, AG1288, and A1 (Alexis Corp., San Diego, Calif.) were prepared in dimethyl sulfoxide (DMSO). The concentration of DMSO in the treatment media was equalized, less than 0.1% (v/v) in each experiment, and did not affect the parameters studied. When PGHS activity or PGHS-2 mRNA levels were measured, herbimycin A was added to the cells in DMEM-F12 containing 1% FBS for 16 h, which was followed by 50 nM dexamethasone (DEX) treatment in synthetic amniotic fluid for 16 h. In experiments with tyrphostins, the drugs were added in synthetic amniotic fluid 30 min prior to DEX. The inhibitors were present in the media during the steroid treatment period.
Cultures analyzed for tyrosine phosphorylated protein content were preincubated first with DMEM-F12 supplemented with 100 µg·mL -1 bovine serum albumin for 2 h, then DEX was added to the medium for 1 or 2 h. Herbimycin A was present in the media for 16 h before DEX addition and during the DEX-treatment intervals.
PGHS activity measurements and evaluation
The activity of PGHS was assessed by measuring the prostaglandin E 2 production of the cells in the presence of exogenous arachidonic acid. Fresh synthetic amniotic fluid containing 10 µM arachidonic acid was added to the cultures for 1 h, and the amount of PGE 2 produced was determined by a specific radioimmunoassay as described . PGE 2 output was normalized to the protein content of the cultures. Concentration-response curves to the tyrosine kinase inhibitors, determined in three or four independent experiments using six parallel-treated cultures, were evaluated by two-way ANOVA followed by the Student-Newman-Keuls test. IC 50 values were determined by linear regression analysis of logarithmically transformed enzyme activity data. Mean IC 50 values, obtained in four experiments with each inhibitor, were compared using the paired or unpaired t-test, as appropriate. A value of p < 0.05 was considered significant.
PGHS-2 mRNA
The abundance of PGHS-2 mRNA and, for reference, γ-actin mRNA in the cytoplasmic RNA fraction was determined by ribonuclease protection assays. The procedures for RNA isolation, probe generation, and ribonuclease protection analysis have been described previously . Messenger RNA abundance was quantified by densitometry of the respective autoradiographic bands using a Bio-Rad model GS-670 imaging densitometer.
Analysis of tyrosine-phosphorylated proteins
The cells were rinsed with cold phosphate-buffered saline and lysed in buffer containing 137 mM NaCl; 5 mM EDTA; 1 mM sodium orthovanadate; 1 mM phenylmethylsulfonyl fluoride; 10 µM leupeptin; 0.15 U·mL -1 aprotinin; 1% (v/v) Triton X-100; 50 mM Tris-HCl, pH 7.5. The 12 000 × g supernatant of the lysates was separated by SDS-PAGE and analyzed by immunoblotting, using a horseradish peroxidase conjugated monoclonal antiphosphotyrosine antibody (1:2500 dilution, clone 4G10, UBI, Lake Placid, N.Y.). Immunocomplexes were detected by enhanced chemiluminescence (ECL), following the instructions of the manufacturer (Amersham Canada Ltd., Oakville, Ont.). Figure 1 shows the effect of four tyrosine kinase inhibitors, herbimycin A and tyrphostins A126, A1288, and A1, on PGHS activity in dexamethasone-treated amnion cells. Dexamethasone alone increased PGHS activity in agreement with previous results demonstrating that glucocorticoids induce PGHS activity in these cells by selectively enhancing PGHS-2 expression . The tyrosine kinase inhibitors suppressed the induction of PGHS activity in a concentration-dependent manner. As indicated by the IC 50 values in Table 1 , herbimycin A was significantly (p < 0.05) more effective than AG1288 and A1, and AG126 was a significantly more potent inhibitor than A1. This suggested that the overall order of efficacy was herbimycin A > AG126 > AG1288 > A1. The drugs did not affect PGHS activity in control experiments where they were added to the cultures together with arachidonic acid after agonist treatment (Zakar et al. 1998 ; this study, data not shown). Cell viability was also unimpaired, since no lactic dehydrogenase release in the culture medium was detected (not shown).
Results
Benzoquinonoid anzamycin type antibiotics, such as geldanamycin and herbimycin A, were shown to facilitate glucocorticoid hormone receptor breakdown, a process not necessarily dependent on tyrosine kinase inhibition (Whitesell and Cook 1996; Segnitz and Gehring 1997) . Therefore, we determined the influence of herbimycin A on the tyrosine phosphorylation of amnion cell proteins in order to ascertain the tyrosine kinase inhibitory activity of the drug under our experimental conditions. As shown in Fig. 2 , phosphotyrosine immunoblots detected three major tyrosine-phosphorylated protein fractions (bands I, II, and III) in the detergent extract of unstimulated cells. The molecular sizes of these phosphoproteins were 120, 110, and 77 kDa, respectively. Densitometric evaluation indicated that DEX treatment for 1 or 2 h increased the phosphorylation of the bands slightly (≤ twofold), while herbimycin A pretreatment inhibited the phosphorylation of band II by 85-90%, even in the presence of DEX. These data were in agreement with an Fig. 1 . The effect of (A) herbimycin A, (B) tyrphostin AG126, (C) tyrphostin AG1288, and (D) tyrphostin A1 on PGHS activity induced by dexamethasone in primary amnion cell cultures. Cell cultures were preincubated with increasing concentrations of herbimycin A or tyrphostins for 16 h or 30 min, respectively, and then stimulated by 50 nM dexamethasone for 16 h in the continuous presence of the drugs. PGHS activity was determined after stimulation by adding 10 µM arachidonic acid to the cells in fresh medium for 1 h, and measuring PGE 2 output by radioimmunoassay. Points represent the mean of (A) four or (B, C, D) three independent experiments with six parallel-treated cultures each ± SEM. *Significant (p < 0.05) inhibition relative to the controls treated with steroid only. inhibitory effect of herbimycin A on tyrosine kinase(s) involved in the phosphorylation of amnion cell proteins in band II. On the other hand, the effect of DEX on the level of tyrosine phosphorylation of these or the other phosphoproteins detected in the cell extracts appeared to be minor. The influence of herbimycin A on PGHS induction by the glucocorticoid was also examined by determining its effect on PGHS-2 mRNA accumulation. Ribonuclease protection analysis presented in Fig. 3 demonstrated that herbimycin A pretreatment decreased the stimulation of the steady-state PGHS-2 mRNA level by DEX nearly completely, and had little effect on the abundance of the constitutively expressed γ-actin mRNA. This shows that the mechanism by which the tyrosine kinase inhibitor suppressed PGHS-2 activity included the blocade of mRNA induction.
Discussion
Tyrphostins inhibit protein tyrosine kinases by competing with ATP and (or) the protein substrate (Gazit et al. 1989 ). The various tyrphostins exhibit distinct effectiveness toward the members of this multifarious group of enzymes. Tyrphostin A1 was shown to be a less potent inhibitor than tyrphostin AG126 in an in vitro protein tyrosine kinase assay, and AG1288 was demonstrated to be as efficient as AG126 in suppressing the tyrosine kinase dependent actions of endotoxin in peritoneal macrophages (Novogrodsky et al. 1994) . The relative potency of these tyrphostins as blockers of PGHS induction by DEX was in overall agreement with these findings (Table 1 ), suggesting that their actions in the amnion cells were mediated by tyrosine kinase inhibition.
Herbimycin A facilitates the breakdown of receptor and nonreceptor tyrosine kinases, possibly by binding to critical sulfhydryl groups via its benzoquinone moiety. This results in a rapid and specific loss of a variety of protein tyrosine kinases from the cells (Uehara et al. 1989; Fukazawa et al. 1994; Sepp-Lorenzino et al. 1995) . Moreover, herbimycin A and its analogue, geldanamycin, block the binding of steroid hormones, including glucocorticoids, to their cognate receptors, disrupt steroid receptor function, and promote the breakdown of steroid hormone receptor proteins (Whitesell and Cook 1996; Segnitz and Gehring 1997; Niimi et al. 1997) . The relationship of the loss of tyrosine kinases to the impairment of receptor function is unclear. Geldanamycin and herbimycin A do not block steroid binding to the receptors under cell-free conditions and do not dissociate the receptor -heat shock protein 90 complex, despite their in vitro ability to bind heat shock protein 90. However, they cause a loss of hormone-binding activity in intact cells even before the depletion of receptor protein occurs. The require- Fig. 3 . The effect of herbimycin A on PGHS-2 mRNA level stimulated by dexamethasone. Amnion cell cultures were treated with dexamethasone alone (DEX) or with dexamethasone and herbimycin A (Herb + DEX). Control cultures (Con) were incubated without the drugs. PGHS-2 mRNA (A) and γ-actin mRNA (for reference, B) abundance in the total cytoplasmic RNA fractions was determined by ribonuclease protection assays. The positions of the protected probes and the undigested PGHS-2 cRNA probe (P) are indicated by the arrows. Lane t represents the assay backgrounds determined in the presence of yeast tRNA carrier only. The ratios of the PGHS-2 and γ-actin mRNA band intensities, measured by densitometry, are shown in Fig. 3C . Representative results of three independent experiments are presented. ment of cellular metabolism for the disruption of steroid receptor function by herbimycin A and geldanamycin thus opens up the possibility that tyrosine kinase(s) are involved in maintaining the functional competence of the steroid receptors. This conjecture is supported by the inhibitory effect of another group of tyrosine kinase blockers, the tyrphostins, on glucocorticoid function in the amnion cells (Fig. 1) , and by the selective reduction of protein tyrosine phosphorylation by herbimycin A under conditions when DEX-induced PGHS-2 expression is diminished (Figs. 2 and  3) .
The identity and the exact role of the tyrosine kinase(s) involved in the glucocorticoid induction of PGHS-2 remain to be established. The tyrosine phosphorylation of the glucocorticoid receptor protein itself was not reported to play a role in maintaining hormone-binding activity, although EGF receptor dependent phosphorylation in vitro may diminish steroid-binding capacity (Rao et al. 1987) . Examples for the tyrosine kinase dependent control of corticosteroid function in other cells include the interaction of the receptor with tyrosine-phosphorylated transcription factors (Stoecklin et al. 1997 ) and the regulation of the nuclear export of the glucocorticoid receptor protein (Yang et al. 1997) . Thus, the possibility needs to be considered that tyrosine kinase dependent regulatory mechanisms participate in the amnion cell specific glucocorticoid induction of PGHS-2 expression. Such pathways may have an overall role controlling amnion tissue PGHS levels, since other stimulants of PGHS-2 expression also act in a tyrosine kinase dependent manner (Zakar et al. 1998 ).
In conclusion, we have found that tyrosine kinase inhibitors block the induction of PGHS-2 by DEX in primary cultures of human amnion cells. The molecular mechanism by which tyrosine kinase(s) control the response of amnion cells to glucocorticoids is unclear. The potential importance of this regulation in determining amniotic PGHS activity levels during gestation and at labour warrants further investigation.
